Oncology

Ipsen’s commitment to oncology is demonstrated by its growing portfolio of therapies aimed at helping patients with neuroendocrine tumors.

oncology
rare-diseases

Rare Diseases

Ipsen continues to develop innovative medicines in rare diseases to address conditions with unmet needs, with specific investment in pituitary pathologies and growth disorders.

Neuroscience

Our focus on movement disorders includes improving the mobility, autonomy and quality of life of patients with these very disabling motor disorders. Our involvement in developing neurotoxins dates back over two decades.

neuroscience
products

Products

Discover the products that Ipsen Canada currently offers.

Last update 01/08/2018